NCT04714372 FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT04708054 Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS Status RECRUITING Phase PHASE2/PHASE3
NCT04692948 TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia Status UNKNOWN Phase NA
NCT04679285 Minimal Residual Disease Evaluation on Cryopreserved Ovarian Fragments in Younger Patients Treated for Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT04676243 Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs Physician's Choice in Newly Diagnosed FLT3-ITD+ AML Status WITHDRAWN Phase PHASE3
NCT04671693 A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. Status ACTIVE_NOT_RECRUITING Phase NA
NCT04669210 PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT Status COMPLETED Phase PHASE2
NCT04669067 TL-895 and KRT-232 Study in Acute Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04662294 CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases Status RECRUITING Phase EARLY_PHASE1
NCT04659616 Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia Status RECRUITING Phase PHASE1
NCT04658004 NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT04657081 Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04641910 Validation Study of a New Cytokine-based Dynamic Stratification Based on FLt3 Ligand Plasma Concentration Kinetic Profile and IL-6 Concentration During Induction of Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT04637009 A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms Status TERMINATED Phase PHASE1
NCT04635384 Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test Status ACTIVE_NOT_RECRUITING Phase N/A